BioSpace News Archive

Teva Pharmaceutical Industries Limited Announces Launch of Generic Avapro® and Generic Avalide® in the United States; Awarded 180-Day Period of Marketing Exclusivity

April 2, 2012
·
1 min read
Teva Pharmaceutical Industries Limited Announces Pricing of EUR 1 Billion and CHF 450 Million of Senior Notes, and the Closing of a New JPY 100 Billion Unsecured Syndicated Facility

April 2, 2012
·
1 min read
Amsterdam Molecular Therapeutics (AMT) Announces Results of Extraordinary General Meeting

April 2, 2012
·
2 min read
Pharm Country

Derma Sciences, Inc. Announces Pricing of Underwritten Registered Direct Offering of Common Stock

April 2, 2012
·
1 min read
Drug Development

Ariad Pharmaceuticals, Inc. Presents New Preclinical Data on Ponatinib and AP26113

April 2, 2012
·
1 min read
Therakos, Inc. Launches Lighting Up Lives Anniversary Campaign to Celebrate 25-Year Impact of Innovative Immune Modulation Therapy

April 2, 2012
·
1 min read
Pharm Country

Acorda Therapeutics Launches New Interactive Website Spotlighting Treatment with Ampyra® (Dalfampridine) of Walking Problems in Patients with Multiple Sclerosis

April 2, 2012
·
1 min read
FDA

Fenwal Receives FDA Clearance for Therapeutic Plasma Exchange on Its Amicus® Separator

April 2, 2012
·
1 min read
Genetown

Metamark Genetics, Inc. Completes Proof-of-Concept for Protein-based Prostate Cancer Test

April 2, 2012
·
1 min read
Bio NC

Conversion Right Triggered for Laboratory Corporation of America Holdings (LabCorp)’s Zero Coupon Convertible Subordinated Notes Due 2021

April 2, 2012
·
1 min read